Abstract:BACKGROUND AND OBJECTIVES: <AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">Despite the important role of vitamin D in maintaining bone health, many clinicians are reluctant to treat vitamin D deficiency in kidney stone formers because of the theoretical risk of increasing urinary calcium excretion. This study examined the effect of vitamin D repletion on urinary calcium excretion among stone formers.</AbstractText>DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: <AbstractText Label="DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS" NlmCategory="METHODS">Participants (n=29) were recruited from urology clinics affiliated with New York Presbyterian Hospital. Enrollment criteria included a history of nephrolithiasis, urinary calcium excretion between 150 and 400 mg/d, and a serum 25-hydroxyvitamin D level &lt;30 ng/ml. Participants were given oral ergocalciferol (50,000 IU/wk) for 8 weeks. Serum and 24-hour urine tests were repeated after 8 weeks.</AbstractText>RESULTS: <AbstractText Label="RESULTS" NlmCategory="RESULTS">Levels of 25-hydroxyvitamin D increased significantly after vitamin D repletion (17±6 and 35±10 ng/ml, P&lt;0.001), but mean 24-hour urinary calcium excretion did not change (257±54 and 255±88 mg/d at baseline and follow-up, respectively, P=0.91). However, 11 participants had an increase in urinary calcium excretion ≥20 mg/d; these participants also had an increase in urine sodium excretion, likely reflecting dietary variability. No participant experienced adverse effects from vitamin D, including hypercalcemia.</AbstractText>CONCLUSIONS: <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among stone formers with vitamin D deficiency, a limited course of vitamin D repletion does not seem to increase mean urinary calcium excretion, although a subset of individuals may have an increase. These data suggest that vitamin D therapy, if indicated, should not be withheld solely on the basis of stone disease, but 24-hour urinary calcium excretion should be monitored after repletion.</AbstractText>

Kymographic imaging of laryngeal vibrations

Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam.

Effect of Vitamin D Repletion on Urinary Calcium Excretion among Kidney Stone Formers

Failure of treatment of ununited fractures of the carpal scaphoid.

Effect of Vitamin D Treatment on Dynamics of Stones Formation in the Urinary Tract and Bone Density in Children with Idiopathic Hypercalciuria

Vitamin D Repletion in Kidney Stone Formers: A Randomized Controlled Trial

Epitaxial Growth and Magnetic Properties of Half-Metallic Fe$_{3}$ O$_{4}$ on Si(100) Using MgO Buffer Layer

Changes in Tacrolimus Distribution in Blood and Plasma Protein Binding Following Liver Transplantation

Vitamin D Status in Patients with Recurrent Kidney Stones

Vitamin D, Hypercalciuria and Kidney Stones

Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?

Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women

Effect of two vitamin D repletion protocols on 24-h urine calcium in patients with recurrent calcium kidney stones and vitamin D deficiency: a randomized clinical trial

Vitamin D and Kidney Stones

Vitamin D and kidney stone disease

Safety of calcium and vitamin D supplements, a randomized controlled trial

[Rapid selection of the gradually shortened DNA clones by using PCR amplification].

Chondromatosis of the knee joint 8 months after autologous chondrocyte implantation.

Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis.

Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial